Emerging Markets Earnings Roundup: Bristol Myers Squibb (Part 6)
This article was originally published in PharmAsia News
Executive Summary
Bristol Myers Squibb saw some turbulence for Baraclude sales in China and Japan, but noted Yervoy sales lifted and the company has high hopes for a deal with Ono and its Opdivo oncology treatment.